Tag: Corstasis Therapeutics

Corstasis and U.S. Heart Team Up to Enhance Heart Failure Care

September 25, 2025

Corstasis Therapeutics Inc., a biopharmaceutical company specializing in outpatient treatments for cardiovascular and kidney diseases, has announced a strategic partnership with U.S. Heart and Vascular

Corstasis Names Dr. Amin Medjamia VP of Medical Affairs

September 11, 2025

Corstasis Therapeutics Inc., a company in the early stages of developing treatments for fluid buildup linked to heart, kidney, and liver issues, has welcomed Dr.

Corstasis Therapeutics Adds Sanjeev Narula to Advisory Board

July 23, 2025

Corstasis Therapeutics, a biopharmaceutical company focused on developing new treatments for respiratory illnesses, has announced the appointment of Sanjeev Narula to its Strategic Advisory Board.

Categories

Tag: Corstasis Therapeutics

Corstasis and U.S. Heart Team Up to Enhance Heart Failure Care

Corstasis Names Dr. Amin Medjamia VP of Medical Affairs

Corstasis Therapeutics Adds Sanjeev Narula to Advisory Board

Share With

Recent Posts

Konica Minolta Teams with NewVue for Exa Teleradiology

Fresenius Kabi Nomogram Now Used at BioLife Plasma Centers

Salt AI Adds Biotech and AI Leaders After $10Million Funding

WELL Health Updates on WELLSTAR Growth and Wins

AvantGuard Awarded $2.65 Million in NIH Grants to Advance Next-Generation Antimicrobial Technologies

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands